120 related articles for article (PubMed ID: 1382425)
1. Inhibition of platelet activation by tyrosine kinase inhibitors.
Rendu F; Eldor A; Grelac F; Bachelot C; Gazit A; Gilon C; Levy-Toledano S; Levitzki A
Biochem Pharmacol; 1992 Sep; 44(5):881-8. PubMed ID: 1382425
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets.
Guinebault C; Payrastre B; Sultan C; Mauco G; Breton M; Levy-Toledano S; Plantavid M; Chap H
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):851-6. PubMed ID: 8391259
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase blockers: new platelet activation inhibitors.
Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of phosphatidylinositol 3,4-bisphosphate is regulated by protein-tyrosine phosphorylation but the p85 alpha subunit of phosphatidylinositol 3-kinase may not be a target for tyrosine kinases in thrombin-stimulated human platelets.
Yatomi Y; Ozaki Y; Satoh K; Kume S
Biochim Biophys Acta; 1994 Jun; 1212(3):337-44. PubMed ID: 8199204
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
Martinson EA; Scheible S; Presek P
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
[TBL] [Abstract][Full Text] [Related]
6. The effects of tyrphostins B42 and B46 on equine platelet function and protein tyrosine phosphorylation.
Dillon AM; Heath MF
Biochem Biophys Res Commun; 1995 Jul; 212(2):595-601. PubMed ID: 7542881
[TBL] [Abstract][Full Text] [Related]
7. Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors.
Glaser KB; Sung A; Bauer J; Weichman BM
Biochem Pharmacol; 1993 Feb; 45(3):711-21. PubMed ID: 8442770
[TBL] [Abstract][Full Text] [Related]
8. Tyrphostin inhibits bombesin stimulation of tyrosine phosphorylation, c-fos expression, and DNA synthesis in Swiss 3T3 cells.
Seckl M; Rozengurt E
J Biol Chem; 1993 May; 268(13):9548-54. PubMed ID: 7683655
[TBL] [Abstract][Full Text] [Related]
9. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.
Ohmichi M; Pang L; Ribon V; Gazit A; Levitzki A; Saltiel AR
Biochemistry; 1993 May; 32(17):4650-8. PubMed ID: 7683492
[TBL] [Abstract][Full Text] [Related]
10. Platelet shape change induced by thrombin receptor activation. Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin- and Ca(2+)-independent mechanism.
Negrescu EV; de Quintana KL; Siess W
J Biol Chem; 1995 Jan; 270(3):1057-61. PubMed ID: 7836359
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
Sauro MD; Thomas B
J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
[TBL] [Abstract][Full Text] [Related]
14. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
15. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets.
Salari H; Duronio V; Howard SL; Demos M; Jones K; Reany A; Hudson AT; Pelech SL
FEBS Lett; 1990 Apr; 263(1):104-8. PubMed ID: 1691984
[TBL] [Abstract][Full Text] [Related]
16. Collagen-induced platelet activation mainly involves the protein kinase C pathway.
Karniguian A; Grelac F; Levy-Toledano S; Legrand YJ; Rendu F
Biochem J; 1990 Jun; 268(2):325-31. PubMed ID: 2163606
[TBL] [Abstract][Full Text] [Related]
17. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
18. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase.
Watts SW; Yeum CH; Campbell G; Webb RC
J Vasc Res; 1996; 33(4):288-98. PubMed ID: 8695753
[TBL] [Abstract][Full Text] [Related]
19. Calcium mobilisation controls tyrosine protein phosphorylation independently of the activation of protein kinase C in human platelets.
Falet H; Rendu F
FEBS Lett; 1994 May; 345(1):87-91. PubMed ID: 7515012
[TBL] [Abstract][Full Text] [Related]
20. Tyrphostin 23 blocks phosphorylation of p42 but not p38 mitogen-activated protein kinase by zooxanthellatoxin-A.
Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y
Eur J Pharmacol; 1997 Jan; 319(2-3):375-8. PubMed ID: 9042614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
